Deciphering protein molecular signatures in cancer tissues to aid in diagnosis, prognosis, and therapy

被引:42
作者
Caprioli, RM
机构
[1] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Vandebilt Ingram Canc Ctr, Nashville, TN 37232 USA
关键词
D O I
10.1158/0008-5472.CAN-04-3581
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Protein signatures in disease, a portion of the protein complement of cells that directly reflects disease related changes, provide a unique data set that may be correlated with or be an aid to more effective diagnosis, prognosis, and response to therapy. A recent article in this Journal from the author's laboratory described the protein analysis of glioma tissue and the discovery of protein signatures for assessing the stage of disease as well as their correlation with patient survival. This investigation used direct proteomic analysis of glioma biopsies, the discovery of molecular signatures for stage and outcome, and identification of specific proteins of this signature group. This minireview discusses the background and present state of the technology used in this work and the role that direct tissue analysis can play in the discovery of high-quality protein signatures.
引用
收藏
页码:10642 / 10645
页数:4
相关论文
共 13 条
[1]  
Aldape K, 2000, CANCER-AM CANCER SOC, V88, P2342, DOI 10.1002/(SICI)1097-0142(20000515)88:10<2342::AID-CNCR19>3.0.CO
[2]  
2-X
[3]   Consistency of primary brain tumor diagnoses and codes in cancer surveillance systems [J].
Castillo, MS ;
Davis, FG ;
Surawicz, T ;
Bruner, JM ;
Bigner, S ;
Coons, S ;
Bigner, DD .
NEUROEPIDEMIOLOGY, 2004, 23 (1-2) :85-93
[4]   Profiling and imaging proteins in tissue sections by MS [J].
Chaurand, P ;
Schwartz, SA ;
Caprioli, RM .
ANALYTICAL CHEMISTRY, 2004, 76 (05) :86A-93A
[5]   Proteomics in diagnostic pathology - Profiling and imaging proteins directly in tissue sections [J].
Chaurand, P ;
Sanders, ME ;
Jensen, RA ;
Caprioli, RM .
AMERICAN JOURNAL OF PATHOLOGY, 2004, 165 (04) :1057-1068
[6]   Variation of serum prostate-specific antigen levels - An evaluation of year-to-year fluctuations [J].
Eastham, JA ;
Riedel, E ;
Scardino, PT ;
Shike, M ;
Fleisher, M ;
Schatzkin, A ;
Lanza, E ;
Latkany, L ;
Begg, CB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (20) :2695-2700
[7]   Early changes in protein expression detected by mass spectrometry predict tumor response to molecular therapeutics [J].
Reyzer, ML ;
Caldwell, RL ;
Dugger, TC ;
Forbes, JT ;
Ritter, CA ;
Guix, M ;
Arteaga, CL ;
Caprioli, RM .
CANCER RESEARCH, 2004, 64 (24) :9093-9100
[8]   Proteomic-based prognosis of brain tumor patients using direct-tissue matrix-assisted laser desorption ionization mass spectrometry [J].
Schwartz, SA ;
Weil, RJ ;
Thompson, RC ;
Shyr, Y ;
Moore, JH ;
Toms, SA ;
Johnson, MD ;
Caprioli, RM .
CANCER RESEARCH, 2005, 65 (17) :7674-7681
[9]  
SCHWARTZ SA, 2004, THESIS VANDERBILT U
[10]   Proteomics approaches to uncover the repertoire of circulating biomarkers for breast cancer [J].
Shin, BK ;
Wang, H ;
Hanash, S .
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2002, 7 (04) :407-413